Avatrombopag maleate, a novel thrombopoietin receptor agonist, has emerged as a significant therapeutic agent for the treatment of various myeloid disorders. Its mechanism of action involves augmenting platelet https://jasonufop895162.pointblog.net/avatrombopag-maleate-exploring-its-therapeutic-potential-in-myeloid-disorders-74805154